克氏综合征促凝血失衡:凝血酶生成试验与全血血栓弹力检测
在意大利米兰3家内分泌中心开展的观察性横断面研究纳入58例克氏综合征(KS)患者和58例年龄匹配健康对照,采用凝血酶生成试验(TGA)和全血血栓弹力检测评估凝血平衡。KS患者血小板乏血浆(PPP)和富血小板血浆(PRP)中凝血酶生成增加,且与FVIII水平升高相关,血栓弹力检测证实高凝状态。
要点
- KS患者PPP中凝血酶生成潜力(ETP-TM+)和ETP比值显著高于对照。
- KS患者FVIII、纤维蛋白原及FVIII/蛋白C比值升高,蛋白C水平与对照相当。
- ETP比值与FVIII呈正相关,提示FVIII升高部分解释促凝血失衡。
核心结论
- KS患者存在促凝血失衡,表现为PPP和PRP中凝血酶生成增加,至少部分由FVIII水平升高解释。
- 血栓弹力检测证实KS患者存在高凝状态,可能解释其血栓事件风险。
- 需进一步研究抗血栓预防的获益/风险比。
研究设计与样本
- 观察性横断面研究,在意大利米兰3家三级内分泌中心开展。
- 纳入58例KS患者和58例年龄匹配健康对照。
- 排除接受抗凝或抗血小板治疗及已知凝血障碍者。
主要发现
- KS患者PPP-ETP-TM+均值1528 vs 0.1315 nM×min,P < .001。
- KS患者PPP-ETP比值0.78 vs 0.70,P < .001。
- KS患者FVIII 135% vs 0.107%,P = .001。
- KS患者纤维蛋白原283 vs 0.241 mg/dL,P < .001。
- KS患者FVIII/蛋白C比值1.21 vs 1.06,P < .05;蛋白C两组相当。
关键数值与推荐
- TGA在PPP和PRP中进行,以ETP-TM+、ETP-TM-及ETP比值为促凝血失衡指标。
- 全血血栓弹力检测及凝血因子活性评估。
- ETP比值与FVIII在KS中呈正相关(ρ = 0.538,P < .001)。
临床怎么用
- 对KS患者应关注血栓风险,凝血酶生成试验和血栓弹力检测可辅助评估高凝状态。
- FVIII升高可能是KS促凝血失衡的部分原因,监测FVIII有潜在价值。
- 抗血栓预防需个体化权衡获益与风险。
局限性
- 观察性横断面设计无法推断因果关系。
- 样本量有限(58例KS和58例对照)。
- 未报告抗血栓预防的干预数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Klinefelter syndrome (KS) is a condition at increased risk of thrombosis compared to 46,XY men. OBJECTIVE: This work aimed to investigate the coagulation balance of KS patients by thrombin generation assay (TGA) and thromboelastometry. METHODS: An observational, cross-sectional study was conducted at 3 tertiary endocrinological centers in Milan, Italy. Fifty-eight KS patients and 58 age-matched healthy controls were included. Anticoagulant or antiplatelet therapy and known coagulation disorders were exclusion criteria. TGA was performed in platelet-poor plasma (PPP) and platelet-rich plasma (PRP). Whole-blood thromboelastometry and activities of coagulation factors were assessed. Endogenous thrombin potential (ETP), the area under the thrombin generation curve, assessed with and without thrombomodulin (ETP-TM+ and ETP-TM-), and their ratio (ETP ratio), were considered as indexes of procoagulant imbalance. RESULTS: Patients with KS displayed higher PPP-ETP-TM+ (mean 1528 vs 0.1315 nM × min; P < .001), PPP-ETP ratio (0.78 vs 0.0.70; P < .001), factor (F)VIII (135% vs 0.107%; P = .001), fibrinogen (283 vs 0.241 mg/dL; P < .001), and FVIII/protein C ratio (1.21 vs 0.1.06; P < .05) compared to controls. Protein C was comparable in the 2 groups. Similar results were observed in PRP. The ETP ratio was positively associated with FVIII (ρ = 0.538, P < .001) in KS. Thromboelastometry parameters confirmed evidence of hypercoagulability in KS. CONCLUSION: Patients with KS display a procoagulant imbalance expressed by increased thrombin generation both in PPP and PRP, which is at least in part explained by increased FVIII levels. The procoagulant imbalance, which was confirmed by thromboelastometry, may be responsible for the thrombotic events observed in these patients. Further investigation on the benefit/risk ratio of antithrombotic prophylaxis is warranted.
引用
- Indirli R, Ferrante E, Scalambrino E, et al. Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry. J Clin Endocrinol Metab. 2021. PMID: 33382882. doi:10.1210/clinem/dgaa936
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。